- Home
- PLRZ vs MTNB Comparison
PLRZ vs MTNB Comparison
Compare PLRZ & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- MTNB
- Stock Information
- Founded
- PLRZ 2005
- MTNB 2013
- Country
- PLRZ Israel
- MTNB United States
- Employees
- PLRZ N/A
- MTNB N/A
- Industry
- PLRZ
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- PLRZ
- MTNB Health Care
- Exchange
- PLRZ NYSE
- MTNB Nasdaq
- Market Cap
- PLRZ 3.4M
- MTNB 2.7M
- IPO Year
- PLRZ 2024
- MTNB N/A
- Fundamental
- Price
- PLRZ $2.83
- MTNB $0.56
- Analyst Decision
- PLRZ
- MTNB Hold
- Analyst Count
- PLRZ 0
- MTNB 1
- Target Price
- PLRZ N/A
- MTNB N/A
- AVG Volume (30 Days)
- PLRZ 487.1K
- MTNB 83.0K
- Earning Date
- PLRZ 12-24-2024
- MTNB 11-13-2024
- Dividend Yield
- PLRZ N/A
- MTNB N/A
- EPS Growth
- PLRZ N/A
- MTNB N/A
- EPS
- PLRZ N/A
- MTNB N/A
- Revenue
- PLRZ N/A
- MTNB N/A
- Revenue This Year
- PLRZ N/A
- MTNB N/A
- Revenue Next Year
- PLRZ N/A
- MTNB N/A
- P/E Ratio
- PLRZ N/A
- MTNB N/A
- Revenue Growth
- PLRZ N/A
- MTNB N/A
- 52 Week Low
- PLRZ $0.77
- MTNB $0.50
- 52 Week High
- PLRZ $1.97
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- MTNB 32.26
- Support Level
- PLRZ N/A
- MTNB $0.51
- Resistance Level
- PLRZ N/A
- MTNB $0.60
- Average True Range (ATR)
- PLRZ 0.00
- MTNB 0.05
- MACD
- PLRZ 0.00
- MTNB 0.07
- Stochastic Oscillator
- PLRZ 0.00
- MTNB 38.65
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.